EVLO   $0.3159  -14.65% Market Closed

Evelo Biosciences Inc
Total Cash 17.26M
totalCashPerShare 0.912
EBITDA -69.67M
Total Debt 33.95M
quickRatio 0.434
currentRatio 0.476
Total Revenue
debtToEquity
Revenue/Share
ROA -0.83247
ROE
grossProfits
freeCashflow -43.31M
operatingCashflow -73.70M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 17.51M
forwardPE
floatShares 16.69M
sharesOutstanding 18.98M
sharesShort 196.99K
sharesShortPriorMonth 156.44K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.13%
Short Ratio help_outline 0.12%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue -1.417
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -82.35M
trailingEps -15.64%
forwardEps -1.85%
enterpriseToEbitda -0.25
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2023
institutionsCount 10
lastUpdated April 1, 2024, 2:16 p.m.